More clinical biomarkers. More accurately. Faster than ever.

More clinical biomarkers. More accurately. Faster than ever.

A major challenge of clinical &  translational research is to discover potential, clinically relevant biomarkers in a reliable way. Then, moving beyond positive identification discovery to verification and validation in the shortest possible time. Mass spectrometry potentially enables new screening and clinically relevant tests and supports developing targeted therapeutics.

Bridging the gap from discovery to verification and validation requires high-performing instruments and software, as well as high-level competence in MS-based biomarker discovery and in method development for biomarker verification.

Speak to a specialist

Unless otherwise noted, all products are for research use only, not for use in diagnostic procedures.

Featured mass spectrometry products
Orbitrap Exploris 480 Mass Spectrometer
FAIMS Pro Interface

Mass Spectrometry Instruments

Childrens Hospital Boston
Bringing Mass Spectrometry into Your Laboratory

Critical Consideration for Success

Mark Kellogg, PhD, DABCC, Associate Director of Chemistry at Boston Children’s Hospital discusses his road to bringing mass spectrometry in his laboratory and what you need to know adequately prepare.

Watch this webinar

LC-MS Solutions Orbitrap HRAM MS
Orbitrap HRAM MS
TSQ Triple Quadrupole MS
TSQ Triple Quadrupole MS
Non targeted screening  
Targeted screening
Non-targeted and targeted screening  
Targeted quantitation
Retrospective analysis  
= Not applicable = Poor = Good = Better = Best
LC-MS Solutions Orbitrap HRAM MS
Orbitrap HRAM MS
TSQ Triple Quadrupole MS
TSQ Triple Quadrupole MS
Non targeted screening  
Targeted screening
Non-targeted and targeted screening  
Targeted quantitation
Retrospective analysis  
= Not applicable = Poor = Good = Better = Best